fluorodeoxyglucose f18 has been researched along with Clinical Deterioration in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Asmar, A; Fjordside, L; Mens, H | 1 |
Błaszczak, P; Hładuński, M; Kamiński, K; Kazimierczyk, R; Małek, Ł; Myśliwiec, J; Nekolla, S; Sobkowicz, B; Szumowski, P; Tarasiuk, E | 1 |
Ikeda, T; Iwamoto, S; Kadowaki, T; Kimura, M; Kobayashi, K; Minamizaki, T; Nagaoka, S; Nishikawa, E; Tada, M; Tajima, F; Yano, S | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Clinical Deterioration
Article | Year |
---|---|
Using 18F-FDG PET/CT to rule out Richter transformation as cause of deterioration in a patient with chronic lymphatic leukemia and severe COVID-19: A case report.
Topics: Clinical Deterioration; COVID-19; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Platelet sTWEAK and plasma IL-6 are associated with 18F-fluorodeoxyglucose uptake in right ventricles of patients with pulmonary arterial hypertension: A pilot study.
Topics: Clinical Deterioration; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Heart Ventricles; Humans; Hypertension, Pulmonary; Interleukin-6; Pilot Projects; Pulmonary Arterial Hypertension; Tumor Necrosis Factors | 2022 |
Askin's tumor in an elderly patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Clinical Deterioration; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymph Nodes; Male; Mediastinum; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Thoracic Wall | 2019 |